Viewing Study NCT00204061



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00204061
Status: COMPLETED
Last Update Posted: 2014-12-24
First Post: 2005-09-12

Brief Title: Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Sponsor: University of Cologne
Organization: University of Cologne

Study Overview

Official Title: Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Status: COMPLETED
Status Verified Date: 2014-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study will provide an empirical basis for a pharmacological treatment option An open-label randomized multi-centre parallel group design is used An intensified clinical management CM which allows needs-based psychological crisis intervention is compared to a combination of such a CM and the atypical neuroleptic amisulpride The central hypothesis is that the combination of a clinical management with an atypical neuroleptic is the superior treatment
Detailed Description: The first diagnosis of schizophrenia is preceded by a long lasting period comprising an untreated psychotic and a prodromal state The duration of untreated psychosis correlates with a significant worsening of several outcome variables and persons fulfilling criteria of a prodromal state are already suffering from prodromal symptoms and from a significant deterioration of social and vocational functioning However a sufficient strategy for early intervention is still lacking The study will provide an empirical basis for a pharmacological treatment option An open-label randomized multi-centre parallel group design is used An intensified clinical management CM which allows needs-based psychological crisis intervention is compared to a combination of such a CM and the atypical neuroleptic amisulpride For analysis 130 patients will be recruited within three years the treatment period is two years

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None